Review

Lipoprotein(a) and Prostate Cancer: A Systematic Review of Observational, Genetic and Mendelian Randomization Evidence

Figure 1. PRISMA flow diagram illustrating the identification, screening, eligibility assessment, and inclusion of studies in the systematic review.
Open the figure at full size
Figure 1. PRISMA flow diagram illustrating the identification, screening, eligibility assessment, and inclusion of studies in the systematic review.PRISMA flow diagram illustrating the identification, screening, eligibility assessment, and inclusion of studies in the systematic review.Kisiała et al. · CC BY

International Journal of Molecular Sciences

Abstract

Cancer is a major cause of morbidity worldwide. Prostate cancer (PCa) is one of the most commonly diagnosed malignancies in men and is clinically heterogeneous, highlighting the need for additional biomarkers that may improve risk stratification.

The paper

Wroclaw Medical University

International Journal of Molecular Sciences · 17 Sep 2026 · CC BY

doi.org/10.3390/ijms27188274PubMed 42794701

More on Prostate cancer